Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
15 - Patterns of growth: relevance to developmental origins of health and disease
Published online by Cambridge University Press: 08 August 2009
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
Summary
Introduction
Epidemiological studies have contributed enormously to our understanding of the natural history of many non-communicable diseases like coronary heart disease (CHD) and type 2 diabetes. Although clinical manifestations of these conditions normally become evident in adult life, early signs are recognisable already in children (Holman et al. 1958, Strong and McGill 1962, Berenson et al. 1979). A greater understanding of the evolution of many chronic diseases and their risk factors early in life is important for their primary prevention as well as in order to get a better understanding of the disease pathogenesis. The discovery that people who develop CHD and many of its risk factors in adult life grow differently during early life has led to the recognition of new developmental models for the disease and its risk factors. In this chapter, patterns of growth will be focused upon primarily in relation to CHD and type 2 diabetes as disease outcomes.
Prenatal growth
David Barker proposed that the epidemic of CHD in Western countries might have its origin in fetal life. He observed that areas in the UK with the highest rates of neonatal mortality in the 1910s and 1920s had the highest rates of CHD in the 1970s and 1980s. Based on these observations he postulated that impaired fetal growth predisposes to heart disease in adult life; studies in Hertfordshire, UK, proved the hypothesis to be correct (Osmond et al. 1993).
- Type
- Chapter
- Information
- Developmental Origins of Health and Disease , pp. 223 - 232Publisher: Cambridge University PressPrint publication year: 2006
References
, , . et al. (2004). Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N. Engl. J. Med., 350, 865–75.CrossRefGoogle Scholar
, , , and (1989). Weight in infancy and death from ischaemic heart disease. Lancet, 2, 577–80.CrossRefGoogle ScholarPubMed
., , and (2002). Growth and living conditions in childhood and hypertension in adult life: a longitudinal study. J. Hypertens., 20, 1951–6.CrossRefGoogle ScholarPubMed
, , , , and (2003). Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia, 36, 62–7.CrossRefGoogle Scholar
, , et al. (1979). Cardiovascular disease risk factor variables during the first year of life. Am. J. Dis. Child., 133, 1049–57.Google ScholarPubMed
(2001). Commentary: early ‘catch-up’ growth is good for later health. Int. J. Epidemiol., 30, 1330–1.CrossRefGoogle ScholarPubMed
and (2002). Childhood growth and coronary heart disease in later life. Ann. Med., 34, 157–61.CrossRefGoogle ScholarPubMed
, , , , and (1999). Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ, 318, 427–31.CrossRefGoogle ScholarPubMed
, , , and (2001). Early growth and coronary heart disease in later life: longitudinal study. BMJ, 322, 949–53.CrossRefGoogle ScholarPubMed
, , , , and (2002a). Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia, 45, 342–7.CrossRefGoogle Scholar
, , et al. (2002b). The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes, 51, 2321–4.CrossRefGoogle Scholar
, , and (2003a). Pathways of infant and childhood growth that lead to type 2 diabetes. Diabetes Care, 26, 3006–10.CrossRefGoogle Scholar
, , , and (2003b). Early adiposity rebound in childhood and risk of type 2 diabetes in adult life. Diabetologia, 46, 190–4.CrossRefGoogle Scholar
, , and (2003c). Obesity from cradle to grave. Int. J. Obes. Relat. Metab. Disord., 27, 722–7.CrossRefGoogle Scholar
, , et al. (2003d). The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth. Clin. Genet., 64, 366–70.CrossRefGoogle Scholar
, , et al. (2003e). Interactions between peroxisome proliferator-activated receptor gene polymorphism and birth length influence risk for type 2 diabetes. Diabetes Care, 26, 2476–7.CrossRefGoogle Scholar
, , , and (2004). Exercise protects against type 2 diabetes in persons with a small body size at birth. Prev. Med., 39, 164–7.CrossRefGoogle ScholarPubMed
(1977). Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease?Br. J. Prev. Soc. Med., 31, 91–5.Google ScholarPubMed
, , , and (1999). Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ, 319, 1403–7.CrossRefGoogle ScholarPubMed
, , , , and (2000). The fetal and childhood growth of persons who develop type 2 diabetes. Ann. Intern. Med., 133, 176–82.CrossRefGoogle ScholarPubMed
, , and (2004). Growth of girls who later develop coronary heart disease. Heart, 90, 20–4.CrossRefGoogle ScholarPubMed
, , , and (1996). Birthweight, adult risk factors and incident coronary heart disease: the Caerphilly study. Public Health, 110, 139–43.CrossRefGoogle ScholarPubMed
, , et al. (1991). Fetal and infant growth and impaired glucose tolerance at age 64. BMJ, 303, 1019–22.CrossRefGoogle ScholarPubMed
, , and (1958). The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am. J. Pathol., 34, 209–35.Google ScholarPubMed
, , , and (2003). The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood. The Bogalusa Heart Study. Diabetes, 52, 1265–9.CrossRefGoogle ScholarPubMed
, , , , and (1996). Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50–60 years. BMJ, 312, 406–10.CrossRefGoogle ScholarPubMed
, , , , and (1994). Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?BMJ, 308, 942–5.CrossRefGoogle ScholarPubMed
and (2001). Compensation for a bad start: grow now, pay later?Trends Ecol. Evol., 16, 254–60.CrossRefGoogle ScholarPubMed
, , et al. (2004). Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia, 47, 1064–70.CrossRefGoogle ScholarPubMed
, , , and (1993). Early growth and death from cardiovascular disease in women. BMJ, 307, 1519–24.CrossRefGoogle ScholarPubMed
, , et al. (1997). Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ, 315, 396–400.CrossRefGoogle Scholar
, , et al. (1999). Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann. Intern. Med., 130, 278–84.CrossRefGoogle ScholarPubMed
, , , , and (1984). Adiposity rebound in children: a simple indicator for predicting obesity. Am. J. Clin. Nutr., 39, 129–35.CrossRefGoogle ScholarPubMed
, , , , and (1987). Tracking the development of adiposity from one month of age to adulthood. Ann. Hum. Biol., 14, 219–29.CrossRefGoogle Scholar
, , et al. (2000). Coronary heart disease after prenatal exposure to the Dutch famine, 1944–45. Heart, 84, 595–8.CrossRefGoogle ScholarPubMed
and (2004). Early origins of cardiovascular disease: is there a unifying hypothesis?Lancet, 363, 1642–5.CrossRefGoogle Scholar
, , and (2003). Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet, 361, 1089–97.CrossRefGoogle ScholarPubMed
, , , and (2004). Is slower early growth beneficial for long-term cardiovascular health. Circulation, 109, 1108–13.CrossRefGoogle ScholarPubMed
, , , , and (1996). Fetal growth and coronary heart disease in South India. Lancet, 348, 1269–73.CrossRefGoogle ScholarPubMed
and (1962). The natural history of coronary atherosclerosis. Am. J. Pathol., 40, 37–49.Google ScholarPubMed
, , and (2003). β-cell capacity and insulin sensitivity in prepubertal children born small for gestational age: influence of body size during childhood. Diabetes, 52, 1756–60.CrossRefGoogle ScholarPubMed
, , et al. (2003). Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care, 26, 343–8.CrossRefGoogle ScholarPubMed
, , , and (1998). Early adiposity rebound and the risk of adult obesity. Pediatrics, 101, 1–6.CrossRefGoogle ScholarPubMed
(2004). Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J. Nutr., 134, 205–10.CrossRefGoogle ScholarPubMed
- 3
- Cited by